Abstract
Digitalis electrophysiology is straightforward by comparison with the impenetrable controversy which surrounds its use in chronic heart failure. In the following account, inotropic effects are mentioned only en passant, and the term digitalis is used to describe all glycoside- like compounds, whether or not derived from digitalis plants. Cardiac glycosides elude attempts to locate their electrophysiological actions within standard antiarrhythmic drug classifications. Effects differ in various parts of the heart, and interactions with the autonomic nervous system contribute substantially to the overall response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Colucci, W. S., Wright, R.F. and Braunwald, E. (1983). New positive inotropic agents in the treatment of congestive heart failure. N. Engl. J. Med., 314, 349 – 58
Hayward, R., Greenwood, H., Stephens, J. and Hamer, J. (1983). Relationship between myocardial uptake and actions in heart failure of methyldigoxin. Br. J. Clin. Pharmacol., 15, 41 – 8
Katz, A. M. (1985). Effects of digitalis on cell biochemistry: sodium pump inhibition. J. Am. Coll. Cardiol., 5, 16A–21A
Schwartz, A. and Adams, R.J. (1980). Studies on the digitalis receptor. Clin. Res., 46 (Suppl 1) I-154–I-160
Wasserstrom, J. A., Schwartz, D.J. and Fozzard, H. A. (1983). Relation between intracellular sodium and twitch tension in sheep cardiac Purkinje strands exposed to cardiac glycosides. Circ. Res., 52 , 697–705
Lee, C. O. (1985). 200 years of digitalis. Am. J. Physiol., 249, C367–78
Poole-Wilson, P. A., Galindez, E. and Fry, C. H. (1979). Effect of ouabain in therapeutic concentrations on K exchange and contraction of human and rabbit myocardium. Clin. Sci., 57, 41520
Hougen, T. J., Lloyd, B. L. and Smith, T. W. (1979). Effects of inotropic and arrhythmogenic digoxin doses and of digoxin specific antibody on myocardial monovalent cation transport in the dog. Circ. Res., 44, 23 – 31
Godfraind, T., DePover, A., Hernandez, G. C. and Fagoo, M. (1982). Cardiodigin: endogenous digitalis-like material from mammalian heart. Arch. Int. Pharmacodyn., 258, 165 – 7
Noble, D. (1980). Mechanism of action of therapeutic levels of cardiac glycosides. Cardiovasc. Res., 14, 495 – 514
Bernabei, R. and Vassale, M. (1984). The inotropic effects of strophanthidin in Purkinje fibers and the sodium pump. Circulation, 69, 618 – 31
Anon. (1983). Endogenous foxglove. Lancet, 2, 1463 – 4
Graves, S. W., Brown, B. and Valdes, R. (1983). An endogenous digoxin-like substance in patients with renal impairment. Ann. Intern. Med., 99, 604 – 8
Kaye, G.C., Williams, A. and Camm, A.J. (1986). Digoxin-like immunoreactivity during atrial arrhythmias. Lancet, 1, 689
Pudek, M.R., Seccombe, D. W., Whitfield, M.F. and Ling, E. (1983). Digoxin-like immunoreactivity in premature and full-term infants not receiving digoxin therapy. N. Engl. J. Med’., 308, 904 – 5
Shimoni, Y, Gotsman, M., Deutsch, J., Kachalsky, S. and Licjtstein, D. (1982). Endogenous ouabain-like compound increases heart muscle contractility. Nature, 307, 369 – 71
de Wardener, H. E. and Clarkson, E. M. (1982). The natriuretic hormone: recent developments. Clin. Sci., 63, 415 – 20
Erdmann, E. and Brown, L. (1983). Cardiac glycoside-receptor system. Eur. Heart J., 4(Suppl. A), 61 – 5
Godfraind, T. (1984). Subclassification of cardiac glycoside receptors. In Erdmann, E. (ed.) Cardiac Glycoside Receptors and Positive Inotropy. Suppl. to Basic Researches in Cardiology, 79, 27 – 34. ( Darmstadt: Steinkopf Verlag. )
Rosen, M.R., Gelband, H. and Hoffman, B.F. (1973). Correlation between effects of ouabain on the canine electrocardiogram and transmembrane potentials of isolated Purkinje fibers. Circulation, 47, 65 – 72
Marban, E. and Tsien, R. W. (1982). Enhancement of calcium current during digitalis inotropy in mammalian heart: positive feed-back regulation by intracellular calcium? J. Physiol., 329, 589 – 614
Hayward, R., Hamer, J., Taggart, P. and Emanuel, R. (1983). Observations on the biphasic nature of digitalis electrophysiological actions in the human right atrium. Cardiovasc. Res., 17, 533 – 46
Rosen, M.R. (1985). Cellular electrophysiology of digitalis toxicity. J. Am. Coll. Cardiol., 5, 22A–34A
Smith, T. W., Antman, E. M., Friedman, P. L., Blatt, C. M. and Marsh, J. D. (1984). Digitalis glycosides: mechanisms and manifestations of toxicity. Part II. Prog. Cardiovasc. Dis., 26, 495 – 540
Di Gennaro, M., Vassale, M., Iacono, G., Pahor, M., Bernabei, R. and Carbonin, P. U. (1986). On the mechanisms by which hypoxia eliminates digitalis-induced tachyarrhythmias. Eur. Heart J., 7, 341 – 52
Goodman, D.J., Rossen, R.M., Cannom, D.S., Rider, A. K. and Harrison, D. C. (1975). Effect of digoxin on atrioventricular conduction. Studies in patients with and without cardiac autonomic innervation. Circulation, 151, 251 – 6
Rosen, M.R., Wit, A. L. and Hoffman, B.F. (1975). Electrophysiology and pharmacology of cardiac arrhythmias. IV. Cardiac antiarrhythmic and toxic effects of digitalis. Am. Heart. J., 89, 391 – 9
Alboni, P., Shantha, N., Filippi, L., Pirani, R., Preziosis, S., Tomasi, A.M. and Masoni, A. (1984). Clinical effects of digoxin on sinus node and atrioventricular node function after pharmacologic autonomic blockade. Am. Heart. J., 108, 1255 – 61
Gomes, J.A.C., Damato, A.N., Bobb, G. A. and Lau, S. H. (1978). The effect of digitalis on refractoriness of the intact canine His-Purkinje system. Circulation, 58, 284 – 94
Gould, L., Patel, C., Botzu, R., Judge, D. and Lee, J. (1986). Right bundle branch block: a rare manifestation of digitalis toxicity - case report. Angiology, 37, 543 – 6
Spurrell, R. A. J., Harris, A. M. and Howard, M. R. (1971). Effect of digoxin on A- V conduction. Br. Med. J., 3, 563 – 4
Bissett, J. K., deSoyza, N. D.B., Kane, J. J., McConnell, J. R. and Doherty, J.E. (1978). Effect of digitalis on human ventricular refractoriness. Cardiovasc. Res., 12, 288 – 93
Edvardsson, N., Hirsch, I. and Olssen, S.B. (1984). Acute effects of lignocaine, procainamide, metoprolol, digoxin and atropine on human myocardial refractoriness. Cardiovasc. Res., 18, 463 – 70
Watanabe, A.M. (1985). Digitalis and the autonomic nervous system. J. Am. Coll. Cardiol., 5, 35A–42A
Sellers, T.D., Bashore, T.M. and Gallagher, J.J. (1977). Digitalis in the preexcitation syndrome. Circulation, 56, 260 – 7
Gillis, R. A. and Quest, J. A. (1979). The role of the nervous system in the cardiovascular effects of digitalis. Pharmacol. Rev., 31, 19 – 97
Longhurst, J. C. and Ross, J. Jr. (1985). Extracardiac and coronary vascular effects of digitalis. J. Am. Coll. Cardiol., 5, 99A–105A
Somberg, J. C. (1984). Localization of neurally mediated arrhythmogenic and coronary vasoconstrictor properties of digitalis. Fed. Proc., 43, 2963 – 5
Tanz, R. D. (1986). Possible contribution of digitalis-induced coronary constriction to toxicity. Am. Heart. J., Ill, 812 – 17
DeMots, H., Rahimtoola, S.H., McAnulty, J.H. and Porter, G. A. (1978). Effects of ouabain on coronary and systemic vascular resistance and myocardial oxygen consumption in patients without heart failure. Am. J. Cardiol., 41, 88 – 93
Chamberlain, D. A. (1985). Digitalis: where are we now? Br. Heart J., 54, 227 – 33
Hoffman, B. F., Bigger, J. T. (1980). Digitalis and allied glycosides. In Gilman, A. G., Goodman, L. S. and Gilman, A. (eds.) The Pharmacological Basis of Therapeutics. 6th edn. pp. 729–60. ( NY: Macmillan ) 729 – 60
Meijler, F. L. (1986). Editorial: the pulse in atrial fibrillation. Br. Heart. J., 56, 1 – 3
Meijler, F. L. (1985). An ‘account’ of digitalis and atrial fibrillation. J. Am. Coll. Cardiol., 5, 60A–68A
Rawles, J. M. and Rowland, E. (1986). Is the pulse in atrial fibrillation irregularly irregular? Br. Heart J., 56, 4 – 11
Breasley, R.A., Smith, D.A. and McHaffie, D.J. (1985). Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation. Br. Med. J., 290, 9 – 11
Panidis, I.P., Morganroth, J. and Baessler, C. (1983). Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis. Am. J. Cardiol., 52, 1197 – 201
Marcus, F. I. (1985). Pharmacokinetic interactions between digoxin and other drugs. J. Am. Coll. Cardiol., 5, 82A–90A
Csicsko, J. F., Schatzlein, M. H. and King, R. D. (1981). Immediate postoperative digitalization in the prophylaxis of supraventricular arrhythmias following coronary artery bypass. J. Thorac. Cardiovasc. Surg., 81, 419 – 22
Saltissi, S., Crowther, A., Byrne, C., Clarke, S., Jenkins, B. S. and Webb Peploe, M. M. (1983). The effects of oral digoxin therapy in primary mitral leaflet prolapse. Eur. Heart J., 4, 828 – 37
Coumel, P., Escoubet, B. and Attuel, P. (1984). Beta-blocking therapy in atrial and ventricular tachyarrhythmias: experience with nadolol. Am. Heart J., 108, 1098 – 108
Weiner, P., Bassan, M. M., Jarchovsky, J., Iusim, S. and Plavnick, L. (1983). Clinical course of acute atrial fibrillation treated with rapid digitalization. Am. Heart J., 105, 223 – 7
Wiggins, J.W. Jr., Bowes, W., Hill, C., Clewell, W., Manco-Johnson, M., Manchester, D., Johnson, R., Appareti, K. and Wolfe, R. R. (1986). Echocardiographic diagnosis and intravenous digoxin management of fetal tacharrhythmias and congestive heart failure. Am. J. Dis. Child., 140, 202 – 4
Ward, D. E. (1987). Arrhythmias and electrophysiological studies in children. Curr. Opin. Cardiol., 2, 76 – 80
Birnbaum, S.E., McGahan, J. P., Janos, G.G. and Myers, M. (1985). Fetal tachycardia and intramyocardial tumors. J. Am. Coll. Cardiol., 6, 1358 – 61
Rey, E., Duperron, L., Gauthier, R., Lemay, M., Grignon, A. and Le Lorier, J. (1985). Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone: a case report. Am. J. Obstet. Gynecol., 153, 311 – 12
Coumel, P. (1985). Medical treatment of arrhythmias in children. How and when using old and new drugs. G. Ital. Cardiol., 15, 795 – 6
Hastreiter, A. R. and Van der Horst, R. L. (1983). Postmortem digoxin tissue concentration and oxygen content in infancy and childhood. Am. J. Cardiol., 52, 330 – 5
Garson, A. Jr. (1986). Dosing the new antiarrhythmic drugs in children: considerations in pediatric pharmacology. Am. J. Cardiol., 57, 1405 – 7
Berman, W. Jr., Yabek, S.M., Dillon, T., Niland, C., Corlew, S. and Christensen, D. (1983). Effects of digoxin in infants with a congested circulatory state due to a ventricular septal defect. N. Engl. J. Med., 308, 363 – 6
Alpert, B. S. and Barfield, J. A. (1985). Reappraisal of digitalis in infants with left- to-right shunts and heart failure. J. Paediatrics., 106, 66 – 8
Klein, G. T., Yee, R. and Sharma, A. D. (1984). Concealed conduction in accessory atrioventricular pathways: an important determinant of the expression of arrhythmias in patients with Wolff-Parkinson-White syndrome. Circulation, 70, 402 – 11
Wu, D., Wyndham, C., Amat-yLeon, F., Denes, P., Dhingra, R. C. and Rosen, K.M. (1975). The effects of ouabain on induction of atrioventricular nodal reentrant paroxysmal supraventricular tachycardia. Circulation, 52, 201 – 7
Gradman, A. H., Cunningham, M., Harbison, M. A., Berger, H. J. and Zaret, B. L. (1983). Effects of oral digoxin on ventricular ectopy and its relation to left ventricular function. Am. J. Cardiol., 51, 765 – 82
Lown, B., Graboys, T. B., Podrid, P. J., Cohen, B. H., Stockman, M. B. and Gaughan, C. E. (1977). Effect of a digitalis drug on ventricular premature beats. N. Engl. J. Med., 296, 301 – 6
Graboys, T. B., Lown, B., Podrid, P.J. and DeSilva, R. (1982). Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am. J. Cardiol., 50, 437 – 3
Morrison, J., Goromilas, J., Robbins, M., Oug, L., Eisenberg, S., Stechel, R., Zema, M., Reiser, P. and Scherr, L. (1980). Digitalis and myocardial infarction in man. Circulation, 62, 8 – 16
Lown, B., Klein, M. D., Barr, I., Hagemeijer, F., Kosowsky, B. D. and Garrison, H. (1972). Sensitivity to digitalis drugs in acute myocardial infarction. Am. J. Cardiol., 30, 388 – 95
Marcus, F.I. (1980). Editorial: use of digitalis in acute myocardial infarction. Circulation, 6, 17–19
Moss, A. J., Davis, H. T., Conard, D. L., DeCamilla, J. J. and Odoroff, C. L. (1981). Digitalis-associated cardiac mortality after myocardial infarction. Circulation, 64, 1150 – 6
Moss, A. J., Davis, H. T., Odoroff, C. L. and Bigger, J. T. (1983). Digitalis-associated mortality in postinfarction patients. Circulation, 68. (Suppl. 3), III–368
Ryan, T.J., Bailey, K.R., McCabe, C.H., Luk, S., Fisher, L.D., Mock, M.B. and Killip, T. (1983). The effects of digitalis on survival in high-risk patients with coronary artery disease. Circulation, 67, 735 – 42
Madsen, E.B., Gilpin, E., Henning, H., Ahnve, S., LeWinter, M., Mazur, J., Shabetai, R., Collins, D. and Ross, J. Jr. (1984). Prognostic importance of digitalis after acute myocardial infarction. J. Am. Coll. Cardiol., 3, 681 – 9
Bigger, J. T. Jr., Fleiss, J. L., Rolnitzky, L. M., Merab, J. P. and Ferrick, K. J. (1985). Effect of digitalis treatment on survival after acute myocardial infarction. Am. J. Cardiol., 55, 623 – 30
Muller, J. E., Tun, Z. G., Stone, P. H., Rude, R. E., Raabe, D. S., Jaffe, A. S., Gold, H. K., Gustafson, W.K., Poole, E., Passamani, E., Smith, T. W., and Braunwald, E. (1986). Digoxin therapy and mortality after myocardial infarction. N. Engl. J. Med., 314, 265 – 71
Yusuf, S., Wittes, J., Bailey, K. and Furberg, C. (1986). Digitalis - a new controversy regarding an old drug. Circulation, 73, 14 – 18
Haber, E. (1985). Antibodies and digitalis: the modern revolution in the use of an ancient drug. J. Am. Col. Cardiol., 5, 111A–117A
Fisch, C. and Knoebel, S.B. (1985). Digitalis and cardiotoxicity. J. Am. Coll. Cardiol., 5, 91A–98A
Whang, R., Oei, T. O. and Watanabe, A. (1985). Frequency of hypomagnesemia in hospitalized patients receiving digitalis. Arch. Intern. Med., 145, 655 – 6
Bain, R.J.I. (1983). Accidental digitalis poisoning due to drinking herbal tea. Br. Med. J., 290, 1624
Lown, B. (1985). Cardioversion and the digitalized patient. J. Am. Coll. Cardiol., 5, 889 – 90
Wenger, T.L., Butler, V. P. Jr., Haber, E. and Smith, T. W. (1985). Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments. J. Am. Coll. Cardiol., 5, 118A–123A
Mann, D.L., Maisel, A.S., Atwood, J. E., Engler, R. L. and LeWinter, M. M. Absence of cardioversion-induced ventricular arrhythmias in patients with therapeutic digoxin levels. J. Am. Coll. Cardiol., 5, 882–8
George, C. F. (1982). Interactions with digoxin: more problems. Br. Med. J., 284, 291 – 2
Cleland, J. G.F., Dargie, H.J., Pettigrew, A., Gillen, G. and Robertson, J. I.S. The effects of captopril on serum digoxin and urinary urea and digoxin clearances in patients with congestive heart failure. Am. Heart J., 112, 130–5
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Hayward, R. (1988). Digitalis and arrhythmias. In: Camm, A.J., Ward, D.E. (eds) Clinical Aspects of Cardiac Arrhythmias. Current Status of Clinical Cardiology, vol 6. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1289-2_19
Download citation
DOI: https://doi.org/10.1007/978-94-009-1289-2_19
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7073-7
Online ISBN: 978-94-009-1289-2
eBook Packages: Springer Book Archive